Innovest Global, Inc. (IVST) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
IVST representa a Innovest Global, Inc., una empresa del sector Industrials con un precio de $ (capitalización de mercado 0). Calificado con 45/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Perfil de Operaciones Industriales de Innovest Global, Inc. (IVST)
Innovest Global, Inc., operating within the industrials sector, focuses on diverse business lines including curtain wall systems, energy services, and biotechnology. With a presence in commercial and industrial sectors, the company also supplies safety equipment and develops immunotherapeutics, positioning itself as a diversified conglomerate.
Tesis de Inversión
Innovest Global, Inc. presents a high-risk, high-reward investment profile due to its presence in multiple sectors, including biotechnology. The company's negative P/E ratio and profit margin of -59.3% indicate financial challenges. Growth catalysts include potential advancements in its immunotherapeutic development and expansion of its energy services. However, the company's OTC listing and negative beta of -0.72 suggest volatility and limited correlation with the broader market. Investors should closely monitor the company's ability to improve profitability and capitalize on its diverse business segments.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Operates in diverse sectors including commercial and industrial, energy, and biotechnology.
- Gross Margin of 34.0% indicates potential for profitability in specific segments.
- Negative Profit Margin of -59.3% reflects current financial challenges.
- Market Cap of $0.00B indicates a micro-cap company with associated risks and potential for growth.
- Beta of -0.72 suggests a negative correlation with the market, potentially offering diversification benefits.
Competidores y Pares
Fortalezas
- Diversified operations across multiple sectors.
- Expertise in curtain wall systems design and engineering.
- Potential for breakthrough in glioblastoma multiforme treatment.
- Established presence in energy services and safety equipment supply.
Debilidades
- Negative profit margin and financial instability.
- OTC listing indicates higher risk and lower liquidity.
- Limited market capitalization and brand recognition.
- Dependence on external factors for energy services demand.
Catalizadores
- Upcoming: Potential positive results from clinical trials of its immunotherapeutic for glioblastoma multiforme.
- Ongoing: Expansion of energy services and securing new contracts.
- Ongoing: Increased demand for curtain wall systems in commercial construction projects.
- Ongoing: Strategic partnerships and acquisitions to expand market reach.
Riesgos
- Potential: Failure in clinical trials for its immunotherapeutic development.
- Potential: Intense competition in all operating sectors.
- Ongoing: Negative profit margin and financial instability.
- Ongoing: OTC listing indicating higher risk and lower liquidity.
- Potential: Economic downturn affecting construction and industrial demand.
Oportunidades de crecimiento
- Expansion of Energy Services: Innovest Global has the opportunity to expand its energy services to meet the growing demand for energy-efficient solutions. The energy services market is projected to reach $120 billion by 2028, driven by increasing awareness of energy conservation and government incentives. By leveraging its expertise in LED lighting and energy brokerage, Innovest can capture a larger share of this market. Timeline: Ongoing.
- Development of Immunotherapeutic for Glioblastoma Multiforme: The company's development of immunotherapeutic for glioblastoma multiforme represents a significant growth opportunity. The global glioblastoma multiforme treatment market is expected to reach $2.5 billion by 2027. Successful development and commercialization of this therapeutic could generate substantial revenue. Timeline: 3-5 years.
- Increased Demand for Curtain Wall Systems: Innovest Global can capitalize on the increasing demand for curtain wall systems in commercial and industrial construction. The global curtain wall market is projected to reach $50 billion by 2025, driven by urbanization and the need for energy-efficient building solutions. By enhancing its design and manufacturing capabilities, Innovest can secure more projects. Timeline: Ongoing.
- Supply of Personal Protective Equipment (PPE): The ongoing need for personal protective equipment (PPE) presents a sustained growth opportunity. The global PPE market is expected to remain strong due to health and safety regulations. Innovest Global can expand its supply chain and distribution network to meet this demand, focusing on quality and competitive pricing. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Innovest Global can pursue strategic partnerships and acquisitions to expand its market reach and service offerings. Collaborating with other companies in the energy, construction, and biotechnology sectors can provide access to new technologies, markets, and expertise. Targeted acquisitions can complement its existing business lines and accelerate growth. Timeline: 1-3 years.
Oportunidades
- Expansion of energy services to meet growing demand.
- Commercialization of immunotherapeutic for glioblastoma multiforme.
- Increased demand for curtain wall systems in construction.
- Strategic partnerships and acquisitions to expand market reach.
Amenazas
- Intense competition in all operating sectors.
- Regulatory changes impacting energy and healthcare industries.
- Economic downturn affecting construction and industrial demand.
- Potential failure in clinical trials for immunotherapeutic development.
Ventajas competitivas
- Diversified business operations across multiple sectors reduces reliance on a single market.
- Proprietary designs and engineering expertise in curtain wall systems.
- Established relationships with suppliers and customers in the energy and safety equipment sectors.
- Potential for intellectual property protection related to its immunotherapeutic development.
Acerca de IVST
Innovest Global, Inc., established in 1999 and based in Chesterland, Ohio, operates as a diversified conglomerate engaging in commercial and industrial, energy, and biotechnology and health services sectors. Originally named Aurum Resource and Asset Management, Inc., the company rebranded to Innovest Global, Inc. in January 2017. Its commercial and industrial segment designs, engineers, tests, and manufactures curtain wall systems, along with negotiating and purchasing various exterior building products. It also supplies personal protection equipment, apparel, and safety supplies. In the energy sector, Innovest Global provides energy services aimed at reducing businesses' overall energy costs, offers LED lighting products, and acts as an independent energy broker. The biotechnology and health services segment focuses on developing immunotherapeutics for treating patients with glioblastoma multiforme. The company also offers inbound and outbound call services.
Qué hacen
- Designs, engineers, tests, and manufactures curtain wall systems.
- Supplies personal protection equipment, apparel, and safety supplies.
- Offers inbound and outbound call services.
- Negotiates and purchases various exterior building products.
- Provides energy services to reduce businesses overall energy costs.
- Offers LED lighting products.
- Acts as an independent energy broker.
- Develops immunotherapeutic for treating patients with glioblastoma multiforme.
Modelo de Negocio
- Generates revenue through the sale of curtain wall systems and related engineering services.
- Earns income from the supply of personal protection equipment and safety supplies.
- Provides energy services and earns commissions as an independent energy broker.
- Seeks to generate revenue through the development and potential commercialization of immunotherapeutics.
Contexto de la Industria
Innovest Global, Inc. operates within the industrials sector, specifically as a conglomerate. This sector is characterized by companies with diverse business operations across multiple industries. The competitive landscape includes companies like BCND, CBCA, LSCG, MEGH and MGLI. Market trends include increasing demand for energy-efficient solutions and advancements in biotechnology. Innovest Global's diversified approach allows it to capitalize on various market opportunities, but also presents challenges in managing diverse operations and maintaining profitability.
Clientes Clave
- Commercial and industrial construction companies requiring curtain wall systems.
- Businesses seeking to reduce energy costs through energy services and LED lighting.
- Organizations requiring personal protection equipment and safety supplies.
- Patients and healthcare providers seeking innovative treatments for glioblastoma multiforme.
Finanzas
Gráfico e información
Precio de la acción de Innovest Global, Inc. (IVST): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para IVST.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para IVST.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para IVST.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de IVST en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Clasificación
Industria ConglomeratesLiderazgo: Sri Vanamali
CEO
Sri Vanamali serves as the CEO of Innovest Global, Inc. His background includes experience in strategic leadership and business development. He has been instrumental in guiding the company through its transition and diversification efforts. His expertise spans across various sectors, including energy, biotechnology, and industrial solutions. Vanamali's leadership focuses on driving innovation and creating shareholder value through strategic initiatives and operational efficiency.
Historial: Under Sri Vanamali's leadership, Innovest Global, Inc. has focused on diversifying its business operations and exploring new growth opportunities. Key milestones include the expansion of energy services and the development of immunotherapeutic for glioblastoma multiforme. His strategic decisions have aimed to position the company for long-term growth and sustainability, despite current financial challenges.
Información del mercado OTC de IVST
The OTC Other tier represents the lowest tier of the OTC market, indicating that Innovest Global, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater price volatility. Unlike NYSE or NASDAQ listings, OTC Other stocks do not have the same stringent listing requirements, resulting in increased risks for investors due to potential lack of transparency and regulatory oversight.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure and transparency.
- Potential for price manipulation due to low trading volume.
- Higher risk of delisting or trading suspension.
- Lack of regulatory oversight compared to listed exchanges.
- Increased volatility and wider bid-ask spreads.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor experienced in OTC stocks.
- Confirm the company's contact information and physical address.
- Company has been in operation since 1999.
- Diversified business operations across multiple sectors.
- Development of immunotherapeutic for a serious medical condition.
- Presence in commercial and industrial sectors with tangible products.
- Company leadership with experience in strategic development.
IVST Preguntas Frecuentes sobre Acciones de Industrials
¿Cuáles son los factores clave para evaluar IVST?
Innovest Global, Inc. (IVST) actualmente tiene una puntuación IA de 45/100, indicando puntuación baja. Fortaleza clave: Diversified operations across multiple sectors.. Riesgo principal a monitorear: Potential: Failure in clinical trials for its immunotherapeutic development.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de IVST?
IVST actualmente puntúa 45/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de IVST?
Los precios de IVST se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre IVST?
La cobertura de analistas para IVST incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en IVST?
Las categorías de riesgo para IVST incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Failure in clinical trials for its immunotherapeutic development.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de IVST?
La relación P/E para IVST compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está IVST sobrevalorada o infravalorada?
Determinar si Innovest Global, Inc. (IVST) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de IVST?
Innovest Global, Inc. (IVST) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Financial data is limited due to OTC status.
- AI analysis pending for IVST.